300142 沃森生物
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(161,675)1,036,5251,133,7691,201,491705,277
投资活动产生之现金流量净额(69,618)(1,266,667)(807,994)(935,186)(977,150)
筹资活动产生之现金流量净额(27,353)(371,031)236,64494,8181,736,440
汇率变动对现金及现金等价物的影响205,4132,2754,069(125)
现金及现金等价物净增加/(减少)(258,626)(595,760)564,694365,1921,464,443
期初现金及现金等价物余额3,759,1034,354,8633,790,1693,424,9771,960,535
期末现金及现金等价物余额3,500,4773,759,1034,354,8633,790,1693,424,977